References
- DranoveDWhiteWDAgency and the organization of health care deliveryInquiry1987244054152961701
- PaulyMVMedicare drug coverage and moral hazardHealth Aff (Millwood)200423111312215002634
- CoulsonNEStuartBCInsurance choice and the demand for prescription drugsSouthern Econ J199511461157
- LundinDMoral hazard in physician prescription behaviorJ Health Econ200019563966211184797
- EisenbergJMWilliamsSVCost containment and changing physicians’ practice behavior. Can the fox learn to guard the chicken coop?JAMA198124619219522017197307
- BlackstoneEAJosephPFThe economics of biosimilarsAm Health Drug Benefits20136846947824991376
- ChauhanDTowseAMestre-FerrandizJThe market for biosimilars: evolution and policy optionsOHE Briefing, No. 45102008Social Science Research Network Available from: http://papers.ssrn.com/sol3/papers.cfm?abstract_id=2641004Accessed May 13, 2015
- RettigRAMedical innovation duels cost containmentHealth Aff (Millwood)19941337277927162
- GreeneHLGoldbergRJBeattieHRussoAREllisonRCDalenJEPhysician attitudes toward cost containment: the missing piece of the puzzleArch Intern Med19891499196619682774777
- Axt-AdamPvan der WoudenJCvan der DoesEInfluencing behavior of physicians ordering laboratory tests: a literature studyMed Care1993317847948366680
- Committee for Medicinal Products for Human UseGuideline on Similar Biological Medicinal ProductsLondonEuropean Medicines Agency2014 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2014/10/WC500176768.pdfAccessed February 19, 2015
- SchückSTexiersNBiosimilars: the French policyInt J Risk Saf Med2009214145
- MellstedtHNiederwieserDLudwigHThe challenge of biosimilarsAnn Oncol200819341141917872902
- NiederwieserDSchmitzSBiosimilar agents in oncology/haematology: from approval to practiceEur J Haematol201186427728821175852
- Agenzia Italiana del Farmaco. AIFAAIFA position paper. I farmaci biosimilari [Biosimilars] Available at: http://www.agenziafarmaco.gov.it/sites/default/files/AIFA_POSITION_PAPER_FARMACI_BIOSIMILARI.pdfAccessed May 13, 2015 Italian
- IngrasciottaYGiorgianniFBolcatoJHow much are biosimilars used in clinical practice? A retrospective Italian population-based study of erythropoiesis-stimulating agents in the years 2009–2013BioDrugs201529427528426169209
- IMS Health [homepage on the internet] Available from: http://www.imshealth.com/portal/site/imshealthAccessed May 13, 2015
- Decreto n. 15 del 30 novembre 2009. [Decree number 15, November 30, 2009] Available from: http://www.aslna3sud.it/regione/DECRETO_15_DELIBERAZIONI_DEL_COMMISSARIO_AD_ACTAAccessed May 13, 2015 Italian
- Decreto commisariale n. 44 del 14/07/2010. [Decree number 44, July 14, 2010] Available from: http://www.aslcaserta.it/portale/Portals/0/doc_pub/2012/ATTIREGIONE/dca_44_Misure%20di%20controllo%20spesa%20farmaceutica.pdfAccessed May 13, 2015 Italian
- Decreto n. 34 del 20.03.2012. [Decree number 34, March 20, 2012] Available from: http://www.aslcaserta.it/portale/Portals/0/doc_pub/2012/ATTIREGIONE/34_Farmaci%20biosimilari.pdfAccessed May 13, 2015 Italian
- Decreto n. 27 del 15.03.2013. [Decree number 27, March 15, 2012] Available from: http://www.arsan.campania.it/documents/10157/59773/DCA_27_13.pdfAccessed May 13, 2015 Italian
- HausteinRde MillasCHöerAHäusslerBSaving money in the European healthcare systems with biosimilarsGenerics Biosimilars Initiat J201213–4120126
- Farfan-PortetMIGerkensSLepage-NefkensIVinckIHulstaertFAre biosimilars the next tool to guarantee cost-containment for pharmaceutical expenditures?Eur J Health Econ201415322322824271016
- SchwartzRKSoumeraiSBAvornJPhysician motivations for nonscientific drug prescribingSoc Sci Med19892865775822648605
- HogerzeilHVPromoting rational prescribing: an international perspectiveBr J Clin Pharmacol1995391167756093
- WeiseMBielskyMCDe SmetKBiosimilars: what clinicians should knowBlood2012120265111511723093622
- GodmanBWettermarkBvan WoerkomMMultiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implicationsFront Pharmacol201417510624987370